Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Maintenance Renal Transplantation”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT00189202
What this trial is testing

Efficacy of Sirolimus-Based, Steroid Avoidance Immunosuppression African Americans

Who this might be right for
End Stage Renal DiseaseKidney Transplantation
University of Michigan 49
Not applicableNot Yet RecruitingNCT07718308
What this trial is testing

CD38 mAb Induction + Azathioprine Maintenance for Chronic Active AMR in Kidney Transplant Recipients

Who this might be right for
Kidney TransplantationAntibody-mediated Rejection
wujianyong 20
Not applicableStudy completedNCT01653847
What this trial is testing

Study in Recipients of Renal Transplant Allograft to Evaluate the Impact of Two Immunosuppressive Regimens

Who this might be right for
End Stage Renal Failure With Renal Transplant
Northwestern University 88
Post-approval studies (Phase 4)Study completedNCT01801280
What this trial is testing

Influence of Pantoprazole on the Bioavailability of MMF and EC-MPS

Who this might be right for
TransplantationImmunosuppressionDrug Interaction
Klemens Budde 20
Large-scale testing (Phase 3)Study completedNCT00267189
What this trial is testing

RESCUE Study - Everolimus in Liver Transplantation Recipients With Renal Insufficiency

Who this might be right for
Liver Transplantation
Novartis Pharmaceuticals 145
Post-approval studies (Phase 4)UnknownNCT03088280
What this trial is testing

Efficacy and Safety of Rabbit Antithymocyte Globulin 3mg/kg in Kidney Transplant Patients Under Steroid-free and CNI Minimization Maintenance Immunosuppressive Regimen

Who this might be right for
Thymoglobulin Dose
Hospital Geral de Fortaleza 200
Testing effectiveness (Phase 2)Study completedNCT00089947
What this trial is testing

Evaluate the Effect of Thymoglobulin and Reduced Doses of Steroids to Prevent Renal Transplant Rejection

Who this might be right for
Renal TransplantationGraft Rejection
Genzyme, a Sanofi Company 150
Testing effectiveness (Phase 2)Study completedNCT03663335
What this trial is testing

Study of Efficacy, Safety, Tolerability, Pharmacokinetic (PK) and Pharmacodynamic (PD) of an Anti-CD40 Monoclonal Antibody, CFZ533, in Kidney Transplant Recipients

Who this might be right for
Kidney Transplantation
Novartis Pharmaceuticals 418
Post-approval studies (Phase 4)Ended earlyNCT00596947
What this trial is testing

Prednisone Withdrawal Versus Prednisone Maintenance After Kidney Transplant

Who this might be right for
Transplants and Implants
University of Pennsylvania 18
Post-approval studies (Phase 4)Study completedNCT00650468
What this trial is testing

Compare Early Steroid Withdrawal and Long-Term Steroid Maintenance Therapy in Kidney Transplant Patients

Who this might be right for
Renal Transplantation
Astellas Pharma Inc 397
Large-scale testing (Phase 3)Study completedNCT00239044
What this trial is testing

An Open Label Study to Evaluate the Tolerability and Safety of Enteric-coated Mycophenolate Sodium (EC-MPS) in Combination With Cyclosporine Microemulsion (CsA-ME) in Maintenance Renal Transplant Recipients

Who this might be right for
Kidney Transplant Recipients
Novartis Pharmaceuticals 40
Not applicableStudy completedNCT01277770
What this trial is testing

Studies of Kidney Transplant Outcome

Who this might be right for
Transplant Recipient (Kidney)Steroid-Free Maintenance ImmunosuppressionPost-Transplant Infections+1 more
University of Minnesota 7,500
Very early researchStudy completedNCT01256983
What this trial is testing

Light for Renal Transplant Recipients Having a Sleep-Wake Dysregulation

Who this might be right for
Renal DiseaseSleep Disorders
University of Basel 30
Not applicableEnded earlyNCT04776954
What this trial is testing

Warming Blanket Comparison Study

Who this might be right for
SurgeryTemperature Change, Body
University of Minnesota 15
Not applicableUnknownNCT03651492
What this trial is testing

Effects of Nocturnal Hypertension on Sleep Quality in Renal Transplant Recipients

Who this might be right for
Hypertension; NephropathyRenal TransplantSleep Disorder
Federico II University 200
Post-approval studies (Phase 4)Study completedNCT00150007
What this trial is testing

Measurement of Patient Reported Outcomes in Renal Transplant Patients With and Without Gastrointestinal (GI) Symptoms (PROGIS)

Who this might be right for
Kidney Maintenance Transplant
Novartis Pharmaceuticals 335
Large-scale testing (Phase 3)Study completedNCT01120028
What this trial is testing

Campath, Calcineurin Inhibitor Reduction and Chronic Allograft Nephropathy

Who this might be right for
Kidney Transplantation
University of Oxford 852
Large-scale testing (Phase 3)Study completedNCT00284934
What this trial is testing

Enteric-coated Mycophenolate Sodium (EC-MPS) With Reduced-dose Tacrolimus Versus EC-MPS With Standard-dose Tacrolimus in Stable Kidney Transplant Recipients

Who this might be right for
Kidney Diseases
Novartis 94
Large-scale testing (Phase 3)Study completedNCT00605345
What this trial is testing

A Study Comparing Subcutaneous Mircera and Darbepoetin Alfa for Maintenance Treatment of Anemia in Kidney Transplant Recipients.

Who this might be right for
Anemia
Hoffmann-La Roche 71
Post-approval studies (Phase 4)Study completedNCT00170820
What this trial is testing

Efficacy and Safety of the Switch From Sirolimus to Everolimus in Stable Maintenance Renal Transplant Patients Receiving a Calcineurin Inhibitor Free Regimen

Who this might be right for
Renal Transplantation
Novartis Pharmaceuticals 20
Next Page